Ataman, Ozlem U <br/><br/>
The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Nov 2012 
 - e447-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2012.05.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic--statistics & numerical data<br/>Clinical Trials, Phase I as Topic--statistics & numerical data<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Clinical Trials, Phase III as Topic--statistics & numerical data<br/>Combined Modality Therapy--methods<br/>Drug Industry--statistics & numerical data<br/>Humans<br/>Molecular Targeted Therapy--methods<br/>Neoplasms--mortality<br/>Radiotherapy--methods<br/>Research Support as Topic--statistics & numerical data